DCX and Stroke: At 30 dayspost-stroke, on the ischemic side of the brain, ISP treatment resulted inclearly increased numbers of DCX+ cells as well as their enhancedmigration toward the stroke penumbra but had no effect on the contralateral side(Figures 3B, 3C, 3F, and 3G, quantification in 3I).